Raymond James & Associates’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,600
| Closed | -$69K | – | 3610 |
|
|
2019
Q2 | $69K | Buy |
+10,600
| New | +$69K | ﹤0.01% | 3412 |
|
|
2019
Q1 | – | Sell |
-13,550
| Closed | -$66K | – | 3589 |
|
|
2018
Q4 | $66K | Sell |
13,550
-5,000
| -27% | -$24.4K | ﹤0.01% | 3330 |
|
|
2018
Q3 | $136K | Hold |
18,550
| – | – | ﹤0.01% | 3353 |
|
|
2018
Q2 | $118K | Buy |
18,550
+1,000
| +6% | +$6.36K | ﹤0.01% | 3340 |
|
|
2018
Q1 | $95K | Buy |
17,550
+4,300
| +32% | +$23.3K | ﹤0.01% | 3243 |
|
|
2017
Q4 | $55K | Sell |
13,250
-17,100
| -56% | -$71K | ﹤0.01% | 3212 |
|
|
2017
Q3 | $292K | Buy |
30,350
+12,600
| +71% | +$121K | ﹤0.01% | 2796 |
|
|
2017
Q2 | $210K | Buy |
+17,750
| New | +$210K | ﹤0.01% | 2927 |
|